Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Age and biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
Oras Alabas, K.J. Mason, Zenas Z N Yiu, Catherine Smith, Richard B. Warren, Christopher Em Griffiths, Juliet N. Barker, Simon Morrison, Anthony Bewley, Ian Evans, Christopher Griffiths, Shehnaz Ahmed, Brian Kirby, Elise Kleyn, Philip Laws, Philip Hampton, Oras Alabas, Kathleen McElhone, Zenas Z N Yiu, Teena Mackenzie, Tess McPherson, Ruth Murphy, Anthony D. Ormerod, Shernaz Walton, Nick J. Reynolds, Alexa R. Shipman, Christina Ye, Olivia Hughes, Richard B. Warren, Richard Weller, Girish Kumar Gupta, Vera Zietemann (2025). Age and biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). , 192(5), DOI: https://doi.org/10.1093/bjd/ljaf017.
Article39 days agoO05 Risk of keratinocyte carcinomas in patients with psoriasis treated with biologic therapy: analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group
Shamarke Esse, Oras Alabas, K.J. Mason, Sarah Ryan, Nick J. Reynolds, Clareann H. Bunker, Christopher Em Griffiths, Adèle C. Green, Richard B. Warren (2024). O05 Risk of keratinocyte carcinomas in patients with psoriasis treated with biologic therapy: analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group. , 191(Supplement_1), DOI: https://doi.org/10.1093/bjd/ljae090.005.
Article39 days agoCharacteristics of ‘super responders’ and ‘super nonresponders’ to first biologic monotherapy for psoriasis: a nested case–control study
K.J. Mason, Oras Alabas, Nick Dand, Richard B. Warren, Nick J. Reynolds, Juliet N. Barker, Zenas Z N Yiu, Catherine Smith, Christopher Em Griffiths, Juliet N. Barker, Simon Morrison, Anthony Bewley, Ian Evans, Christopher Em Griffiths, Shehnaz Ahmed, Brian Kirby, Elise Kleyn, Philip Laws, Philip Hampton, Oras Alabas, Kathleen McElhone, Zenas Z N Yiu, Teena Mackenzie, Tess McPherson, Ruth Murphy, Anthony D. Ormerod, Shernaz Walton, Nick J. Reynolds, Alexa R. Shipman, Christina Ye, Olivia Hughes, Richard B. Warren, Fiona Browne, Ian Evans, Brian Kirby, Linda Lawson, Philip Laws, Teena Mackenzie, Tess McPherson, Ruth Murphy, Caroline Owen, Eleanor Pearson, Josh Richards, Richard B. Warren (2023). Characteristics of ‘super responders’ and ‘super nonresponders’ to first biologic monotherapy for psoriasis: a nested case–control study. , 190(3), DOI: https://doi.org/10.1093/bjd/ljad446.
Article39 days agoThe association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
Oras Alabas, K.J. Mason, Zenas Z N Yiu, Richard B. Warren, Nick Dand, Juliet N. Barker, Catherine Smith, Christopher Em Griffiths, Juliet N. Barker, Simon Morrison, Anthony Bewley, Ian Evans, Christopher Griffiths, Shehnaz Ahmed, Brian Kirby, Elise Kleyn, Philip Laws, Philip Hampton, Oras Alabas, Kathleen McElhone, Zenas Z N Yiu, Teena Mackenzie, Tess McPherson, Ruth Murphy, Anthony D. Ormerod, Shernaz Walton, Nick J. Reynolds, Catherine Smith, Alexa R. Shipman, Christina Ye, Olivia Hughes, Richard B. Warren, Anja Strangfeld, Richard Weller, Girish Kumar Gupta, Vera Zietemann, Juliet N. Barker, Michael R. Barnes, A. David Burden, Paola Di Meglio, Richard Emsley, Anea Evans, Christopher Em Griffiths, Katherine Payne, Nick J. Reynolds, Catherine Smith, Deborah Stocken, Richard B. Warren (2023). The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). , 190(5), DOI: https://doi.org/10.1093/bjd/ljad481.
Article39 days agoEffectiveness and survival of methotrexate versus adalimumab in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
Oras Alabas, K.J. Mason, Zenas Z N Yiu, Richard B. Warren, Mark Lunt, Catherine Smith, Christopher Em Griffiths, Juliet N. Barker, Simon Morrison, Anthony Bewley, Ian M. Evans, Christopher Em Griffiths, Shehnaz Ahmed, Brian Kirby, Elise Kleyn, Philip Laws, Philip Hampton, Oras Alabas, Kathleen McElhone, Zenas Z N Yiu, Teena Mackenzie, Tess McPherson, Ruth Murphy, Anthony D. Ormerod, Shernaz Walton, Nick J. Reynolds, Catherine Smith, Richard B. Warren, Richard Weller, Girish Kumar Gupta, Vera Zietemann (2023). Effectiveness and survival of methotrexate versus adalimumab in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). , 189(3), DOI: https://doi.org/10.1093/bjd/ljad179.
Article39 days ago